A neuropathologist is a physician who specializes in diagnosing diseases of the brain, spinal cord, nerves, and muscles by examining tissue under a microscope and, increasingly, through molecular testing. While neurologists evaluate living patients for symptoms and neurosurgeons operate, the neuropathologist is the person who looks at the actual tissue to determine what is going on at a cellular level. Their diagnoses drive treatment decisions for brain tumors, confirm or reveal neurodegenerative conditions like Alzheimer’s disease after death, and settle forensic questions about head injuries. It is a small specialty with outsized influence on how nervous system diseases are understood and treated.
What the Day-to-Day Work Actually Looks Like
Neuropathologists spend most of their working hours at a microscope or, these days, in front of a high-resolution screen displaying digitized tissue slides. The tissue they examine comes from several sources: biopsies taken during brain or spinal surgery, samples of muscle or peripheral nerve removed for diagnosis, and brain tissue collected during autopsies. Each of these workflows demands different skills and carries different stakes.
In a hospital setting, a neuropathologist might start the morning reviewing slides from a brain tumor that was removed the day before, matching the tissue patterns and molecular markers to the World Health Organization classification system to give the oncology team a precise diagnosis. In the afternoon, the same neuropathologist could be called to the operating room to evaluate a tissue sample in real time while the surgeon waits. Later, they might review muscle biopsy slides for a patient with unexplained weakness, or examine autopsy brain sections to confirm whether a deceased patient had Alzheimer’s disease.
Frozen Sections and Real-Time Surgical Decisions
One of the most high-pressure parts of the job is intraoperative consultation. During brain surgery, the neurosurgeon often needs to know, right then and there, what kind of tissue they are dealing with. Is this mass a high-grade tumor? Is it an infection? Is it normal brain tissue, meaning they have reached the edge of the lesion? To answer these questions while the patient is still on the operating table, the neuropathologist performs what is called a frozen section: the tissue sample is rapidly frozen, sliced into ultra-thin sections, stained, and examined under a microscope, all within roughly fifteen to twenty minutes.
The accuracy of this rapid-fire diagnosis is high but not perfect. A study of 558 consecutive intracranial tumor cases found that frozen section diagnoses agreed with the final pathology report about 90% of the time.1PubMed Central. The diagnostic properties of frozen sections in suspected intracranial tumors: A study of 578 consecutive cases The roughly 10% discrepancy rate exists because frozen sections sacrifice some tissue quality for speed, and certain tumor types look ambiguous when processed this quickly. Despite those limitations, frozen section diagnosis remains a cornerstone of neurosurgical care, often determining whether the surgeon continues to remove tissue or stops to preserve healthy brain.2PubMed Central. Diagnostic Accuracy of Cytology Smear and Frozen Section in Glioma
Brain Tumor Classification
Classifying brain tumors is one of the defining responsibilities of a neuropathologist, and the field has changed dramatically in recent years. The WHO Classification of Tumors of the Central Nervous System, now in its fifth edition published in 2021, serves as the international standard. What makes the current version notable is its heavy reliance on molecular features alongside traditional microscopy.3PubMed Central. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary In past decades, a neuropathologist diagnosed a brain tumor mostly by how its cells looked under the microscope. That approach still matters, but it now works in tandem with genetic and molecular testing that can distinguish tumors that look identical under the microscope but behave very differently in patients.
This shift toward integrating molecular data with microscopic findings has made the neuropathologist’s toolkit considerably more complex.4PubMed Central. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors A tumor that once would have been labeled simply as “glioma, grade II” might now be classified by its specific genetic mutations, methylation profile, and protein expression patterns. Each of these details can change the prognosis and influence whether the patient receives radiation, chemotherapy, or watchful waiting. Getting the classification wrong can mean the wrong treatment, so the stakes are real.
DNA Methylation Profiling and Precision Diagnostics
One of the most significant advances in the field is the use of DNA methylation profiling to classify brain tumors. Every cell in your body has the same DNA, but chemical tags called methyl groups sit on specific spots along that DNA and help control which genes are active. Tumors carry distinctive patterns of these tags, essentially an epigenetic fingerprint, and analyzing that fingerprint can tell a neuropathologist precisely what type of tumor they are dealing with.5PubMed Central. Methylation profiling in neuropathological tumors diagnosis: a comprehensive review
This approach has proven especially useful in challenging cases where conventional microscopy leaves room for doubt. Methylation arrays provide reproducible, objective data that can confirm a diagnosis, reclassify a tumor into a more accurate category, or even identify entirely new tumor types that were previously lumped together with other entities.6Neuro-Oncology. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology A well-known machine learning classifier developed at Heidelberg can distinguish over 100 different molecular brain tumor classes, a level of specificity that even experienced neuropathologists find difficult to achieve by microscopy alone.7Nature Communications. Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Diagnosing Neurodegenerative Diseases
Much of what we know about Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions comes from the work of neuropathologists examining brain tissue after a patient has died. While neurologists diagnose these diseases clinically during life based on symptoms and imaging, a definitive diagnosis still often requires a neuropathologist to look at the brain tissue and identify the characteristic protein deposits, cell loss, and structural changes that define each condition.
In Alzheimer’s disease, for example, the neuropathologist looks for amyloid plaques and neurofibrillary tangles in specific brain regions. In Parkinson’s disease, they look for Lewy bodies. These findings confirm or sometimes overturn the clinical diagnosis. A Finnish study of medico-legal autopsy cases with head injuries, in which neuropathological examination with immunohistochemistry was performed, found that Alzheimer’s disease neuropathologic change and cerebrovascular disease were the most common neurodegenerative findings, each identified in 34 of the 57 cases examined with neurodegenerative staining.8PubMed. Neurodegenerative disease findings in Finnish neuropathologically examined medico-legal autopsy cases with acute head injuries These results illustrate how common underlying neurodegenerative pathology is, even in people whose deaths were attributed to other causes.
Cerebrovascular Disease Under the Microscope
Stroke and vascular dementia are among the leading causes of death and disability worldwide, and neuropathologists play an important role in characterizing the damage these conditions cause. When a neuropathologist examines brain tissue from someone who suffered vascular cognitive impairment, they look for a range of changes in the small blood vessels of the brain: thickening and scarring of vessel walls, tiny infarcts (areas where blood flow was cut off), and the expansion of spaces around blood vessels.9PubMed Central. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
A related condition that neuropathologists frequently encounter is cerebral amyloid angiopathy, or CAA, where the same amyloid protein associated with Alzheimer’s disease accumulates in the walls of blood vessels in the brain rather than in plaques. Pathological evidence of CAA shows up in roughly half of all people over 70, making it remarkably common.10PubMed Central. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction This vascular amyloid deposit damages vessel walls, can lead to small hemorrhages and reduced blood flow, and contributes to cognitive decline. Distinguishing these vascular contributions from “pure” Alzheimer’s pathology matters for understanding what actually caused a patient’s dementia, and that distinction is the neuropathologist’s to make.
Forensic Neuropathology and Chronic Traumatic Encephalopathy
Forensic neuropathology has entered public consciousness largely because of chronic traumatic encephalopathy, or CTE, the degenerative brain disease linked to repetitive head impacts. CTE can only be diagnosed after death, by a neuropathologist examining the brain. The defining feature is an abnormal buildup of a protein called tau in a very specific pattern: clusters around small blood vessels at the depths of the brain’s cortical folds.11PubMed Central. The neuropathology of chronic traumatic encephalopathy
Establishing agreed-upon diagnostic criteria for CTE has been a major effort. A consensus panel of neuropathologists first proposed formal criteria in 2015, and then refined them at a second meeting to address questions about the minimum amount of pathology needed for a diagnosis and how to grade its severity. The panel ultimately proposed a working framework that classifies cases as “Low CTE” or “High CTE” based on the extent and distribution of the tau deposits.12PubMed Central. The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy Without this kind of standardized diagnostic framework, CTE would remain an anecdotal finding rather than a reproducible diagnosis. As routine neuropathology services begin looking for it more systematically, cases are being identified even in settings without obvious links to contact sports.13PubMed Central. Chronic Traumatic Encephalopathy in a Routine Neuropathology Service in Australia
Beyond CTE, forensic neuropathologists handle other high-stakes work, including evaluating brain tissue in suspected cases of Creutzfeldt-Jakob disease (the human prion disease) and in deaths related to HIV infection. These autopsies carry particular safety risks because of the infectious agents involved, requiring strict protocols to protect laboratory staff while still obtaining diagnostic and research-quality tissue.14PubMed. The ‘high-risk’ neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: principles and practice
Muscle and Nerve Biopsies
The “neuro” in neuropathology extends beyond the brain and spinal cord. Evaluating muscle and peripheral nerve biopsies is a core part of the specialty. When a patient has unexplained muscle weakness, wasting, or pain that clinical testing cannot fully explain, a small piece of muscle may be removed surgically and sent to the neuropathologist. They prepare frozen sections using specialized stains that reveal the internal structure of muscle fibers, the distribution of different fiber types, and signs of disease.15Journal of Neuropathology & Experimental Neurology. What Every Neuropathologist Needs to Know: The Muscle Biopsy
The patterns they identify help distinguish between diseases where the problem originates in the nerve supply to the muscle versus diseases where the muscle itself is diseased. They can also identify specific conditions like inflammatory myopathies (where the immune system attacks muscle tissue), muscular dystrophies, and metabolic storage disorders.16PubMed Central. Muscle biopsy evaluation in neuromuscular disorders This diagnostic role is less visible to the public than brain tumor classification, but it directly affects the care of patients with conditions that can be debilitating.
How a Neuropathologist Differs from a Neurologist or Neurosurgeon
People sometimes confuse these three specialties because they all deal with the nervous system, but the distinctions are substantial. A neurologist sees patients in clinic, examines them, orders tests, prescribes medications, and manages chronic conditions like epilepsy, multiple sclerosis, or migraine. A neurosurgeon operates on the brain, spine, and peripheral nerves. A neuropathologist rarely interacts directly with patients. Instead, they work with the tissue: the biopsy the neurosurgeon removed, the autopsy brain, the muscle sample. Their role is diagnostic and consultative.
Training reflects this difference. After medical school, a neuropathologist typically completes a residency in anatomic pathology (or combined anatomic and clinical pathology), which takes three to four years, followed by a one- to two-year fellowship specifically in neuropathology. Some neuropathologists also train in neurology before entering pathology, giving them clinical perspective that enriches their diagnostic work. The specialty is small; neuropathology fellowships in the United States train only a modest number of new specialists each year, and many academic medical centers have just one or two neuropathologists on staff.
Artificial Intelligence and Digital Pathology
Like many fields in medicine, neuropathology is grappling with how artificial intelligence will reshape its work. Historically, pathology has been slower to digitize than fields like radiology, because pathologists work with physical glass slides rather than inherently digital data like CT scans. But that is changing as high-resolution slide scanners become more common, converting tissue slides into enormous digital images called whole-slide images.17PubMed Central. AI‐Based Methods in Neuropathology for Diagnosis and Treatment of Brain Tumors
These digital images are vast, often containing billions of pixels, so AI approaches typically break them into smaller tiles for analysis. Researchers have trained neural networks to classify brain tumors from these digitized slides with varying degrees of success. One effort using publicly available data achieved about 73% accuracy in distinguishing the most aggressive brain tumors from lower-grade ones.18PubMed Central. Optimization of deep learning methods for visualization of tumor heterogeneity and brain tumor grading through digital pathology That is promising but far from replacing a trained neuropathologist, and the field is candid about that gap. Where AI tools seem most useful right now is in flagging regions of interest, providing a second opinion on difficult cases, and helping standardize diagnoses across institutions with different levels of expertise.
Brain Banking and Research
Neuropathologists are not only diagnosticians; they also play a central role in research. Brain banks, which are collections of donated human brain tissue stored and catalogued for scientific study, depend on neuropathologists to characterize the tissue. Every brain that enters a brain bank must be examined, staged for disease, and its findings recorded so that researchers requesting samples know exactly what they are working with.
Collaborative networks of brain banks have been established to standardize how tissue is collected, processed, and shared. In Europe, the BrainNet Europe consortium brought together 19 brain banks to set shared standards for quality, safety, and ethical handling of human brain tissue, and to distribute knowledge among neuroscientists.19Journal of Neuropathology & Experimental Neurology. Brain banking in the United States and Europe: Importance, challenges, and future trends Without the neuropathologist’s careful diagnostic work, brain bank tissue would be of limited scientific value; researchers need to know whether a donated brain showed signs of Alzheimer’s, Parkinson’s, CTE, or no disease at all, and that determination requires expert examination.
Liquid Biopsy and the Question of Less Invasive Diagnostics
A natural question is whether neuropathology will eventually become less necessary as less invasive diagnostic technologies improve. Liquid biopsy, which involves analyzing cell-free DNA shed by tumors into cerebrospinal fluid or blood, is an emerging approach with particular promise in pediatric brain tumors. By detecting tumor-derived DNA fragments in cerebrospinal fluid, clinicians could potentially monitor whether a tumor is growing or responding to treatment without performing another surgery.20Neuro-Oncology Advances. Cerebrospinal fluid liquid biopsy by low-pass whole genome sequencing for clinical disease monitoring in pediatric embryonal tumors
For now, though, liquid biopsy is being developed as a complement to tissue-based diagnosis, not a replacement. A tissue sample examined by a neuropathologist still provides information that circulating DNA cannot: the architecture of the tumor, how it interacts with surrounding brain tissue, and the full range of molecular features needed for WHO classification. Liquid biopsy is most useful for longitudinal monitoring after the initial tissue diagnosis has already been made.
Comparative Neuropathology and Animal Models
Neuropathology is not exclusively a human medical discipline. Comparative neuropathology examines brain diseases in animals, both to advance veterinary medicine and to understand human diseases better. Many of the same age-related brain changes seen in humans, including amyloid plaques and cognitive decline, occur naturally in other species. Companion animals like dogs and cats develop brain atrophy, plaques, and tangles as they age, in patterns that resemble what happens in human Alzheimer’s disease.21Communications Biology. Going beyond established model systems of Alzheimer’s disease: companion animals provide novel insights into the neurobiology of aging
Studying these naturally occurring animal diseases gives researchers something that engineered mouse models often cannot: a window into how neurodegeneration unfolds in a brain that aged normally rather than one that was genetically programmed to develop a disease. Age-related brain pathology has been described in a wide range of domestic and laboratory species, though how much these changes affect the animals’ actual cognitive function is often poorly documented.22PubMed. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases Neuropathologists who work in this comparative space bridge veterinary and human medicine, looking for cross-species patterns that could unlock new approaches to treating conditions we still cannot cure in people.